Dexcom (Nasdaq:DXCM) announced that it entered into a new partnership with Life Time Inc., an operator of athletic country clubs. Life Time Inc., a “health and wellness pioneer,” has more than 170 athletic country clubs across the U.S. The chain of clubs also extends into Canada. In a post on LinkedIn, Dexcom said it announced […]
Diabetes
Medtronic says it has next-gen insulin pumps on the way, more to come from diabetes business
The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say. Speaking at the JP Morgan Healthcare conference this week, CEO Geoff Martha highlighted the potential opportunity in diabetes. “You’ve seen us turn around this business over the last couple of years,” Martha said. “It’s grown above our […]
Analysts say Embecta is ‘heading in the right direction’ following patch pump discontinuation
Analysts called a recent stock sell-off at Embecta (Nasdaq:EMBC) “unwarranted” and believe the company is moving in the right direction despite recent challenges. Late last year, Embecta filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees. This related to the company’s plans to discontinue its insulin patch pump program and restructure. […]
Henry Schein completes acquisition of CGM supplier Acentus
Henry Schein (Nasdaq: HSIC) announced today that it completed the acquisition of substantially all the assets of Acentus. Tampa, Florida-based Acentus, a national medical supplier, specializes in the delivery of continuous glucose monitors (CGMs). The company reports annual revenue of approximately $35 million. Melville, New York-based Henry Schein announced its agreement to acquire the company […]
Insulet rolls out Omnipod 5 in more European countries
Insulet (Nasdaq:PODD) announced today that it launched the Omnipod 5 system in five more European countries. The company now offers the patch-based automated insulin delivery (AID) system in Italy, Denmark, Finland, Norway and Sweden. It comes compatible with both the Abbott FreeStyle Libre 2 Plus and Dexcom G6 continuous glucose monitors (CGMs) in those geographies. […]
Spirit Health to make new CGM available in UK
Spirit Health said on social media that it plans to make a new continuous glucose monitor (CGM) available next month. The company designed its user-friendly CareSens Air CGM to simplify diabetes management. It plans to make the system available in the UK in February, according to a post on LinkedIn. The post reads: “Our new […]
Dexcom expects sales to grow 14% in 2025
Dexcom (Nasdaq:DXCM) today announced preliminary financial results with projections for significant sales growth in 2025. Shares of DXCM dipped 1.5% to $76.57 in mid-morning trading today. The San Diego-based continuous glucose monitor (CGM) maker reported preliminary 2024 revenues of $4.032 billion. That marks an 11% increase over 2023. For 2025, Dexcom anticipates total revenue of […]
Senseonics to consider reverse stock split, reports strong Eversense 365 interest
Senseonics (NYSE:SENS) announced preliminary financial results for 2024 as it considers a reverse stock split. Given a recent appreciation in the company’s share price, Senseonics decided not to proceed with a planned special meeting of stockholders. The company took this decision to consider the stock split. Shares of SENS rose 43% to 62¢ apiece at […]
Hedia, Glooko launch personalized bolus insulin dosing tech
Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support. The solution combines connected care, remote patient monitoring and digital therapeutic technologies. It aims to enhance access for people with type 1 and type 2 diabetes requiring advanced bolus insulin dosing support. The companies kicked off their launch in […]
Tandem inks collab with UVA to develop closed-loop automated insulin delivery tech
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it signed a multi-year R&D collaboration agreement with the University of Virginia (UVA). The collaboration with the UVA Center for Diabetes Technology aims to advance R&D efforts on fully automated, closed-loop insulin delivery systems. Tandem develops its own closed-loop systems, including the t:slim X2 and Mobi pumps, which […]
